US4458079A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Sulfur-containing imidazoles
Assignee: Bristol Myers Co
•
Filing: 1980-08-08
•
Granted: 1984-07-03
•
Expires: 2000-08-08
Abstract
Abstract Novel imidazole mercaptals of the formula ##STR1## wherein each m is independently zero or one; and R 1 and R 2 each are independently selected from (lower)alkyl, cycloalkyl, cycloalkyl(lower)alkyl, phenyl, phenyl(lower)alkyl, thienyl, thienyl(lower)alkyl, pyridyl and pyridyl(lower)alkyl, in which the phenyl and heterocyclic rings optionally may contain from 1 to 3 substituents, and acid addition salts thereof, are useful antimicrobial agents.
Inventors
- 👤 Richard A. Partyka
- 👤 Thomas W. Hudyma
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-03 23:24
CPC Classifications
C; C07; C07D; C07D231/00; C07D231/02; C07D231/10; C07D231/12; A; A61; A61P; A61P31/00; A61P31/04; C07D233/00; C07D233/54; C07D233/56; C07D249/00; C07D249/02; C07D249/08
Claims Analysis
Total Claims: 18
Claim 1
Independent Claim
13 words
The compound which is 1-[2,2-bis(4-methoxybenzylthio)ethyl]-1H-imidazole, or a pharmaceutically acceptable acid addition salt thereof.
Claim 2
Dependent Claim
13 words
The compound which is 1-[2,2-bis(4-methoxybenzylthio)ethyl]-1H-imidazole, or a pharmaceutically acceptable acid addition salt thereof.
Claim 3
Dependent Claim
13 words
The compound which is 1-[2,2-bis(4-methylthiobenzylthio)ethyl]-1H-imidazole, or a pharmaceutically acceptable acid addition salt thereof.
Claim 4
Dependent Claim
13 words
The compound which is 1-[2,2-bis(4-methylthiobenzylthio)ethyl]-1H-imidazole, or a pharmaceutically acceptable acid addition salt thereof.
Claim 5
Dependent Claim
13 words
The compound which is 1-[2,2-bis(4-nitrobenzylthio)ethyl]-1H-imidazole, or a pharmaceutically acceptable acid addition salt thereof.
Claim 6
Dependent Claim
13 words
The compound which is 1-[2,2-bis(4-nitrobenzylthio)ethyl]-1H-imidazole, or a pharmaceutically acceptable acid addition salt thereof.
Claim 7
Dependent Claim
13 words
The compound which is 1-[2,2-bis(4-chlorophenethylthio)ethyl]-1H-imidazole, or a pharmaceutically acceptable acid addition salt thereof.
Claim 8
Dependent Claim
13 words
The compound which is 1-[2,2-bis(4-chlorophenethylthio)ethyl]-1H-imidazole, or a pharmaceutically acceptable acid addition salt thereof.
Claim 9
Dependent Claim
13 words
The compound which is 1-[2,2-bis(cyclohexylmethylthio)ethyl]-1H-imidazole, or a pharmaceutically acceptable acid addition salt thereof.
Claim 10
Dependent Claim
13 words
The compound which is 1-[2,2-bis(cyclohexylmethylthio)ethyl]-1H-imidazole, or a pharmaceutically acceptable acid addition salt thereof.
Claim 11
Dependent Claim
13 words
The compound which is 1-[2-(4-methylbenzylsulfinyl)-2-(4-methylbenzylthio)ethyl]-1H-imidazole, or a pharmaceutically acceptable acid addition salt thereof.
Claim 12
Dependent Claim
13 words
The compound which is 1-[2-(4-methylbenzylsulfinyl)-2-(4-methylbenzylthio)ethyl]-1H-imidazole, or a pharmaceutically acceptable acid addition salt thereof.
Claim 13
Dependent Claim
13 words
The compound which is 1-[2,2-bis(4-carbomethoxybenzylthio)ethyl]-1H-imidazole, or a pharmaceutically acceptable acid addition salt thereof.
Claim 14
Dependent Claim
13 words
The compound which is 1-[2,2-bis(4-carbomethoxybenzylthio)ethyl]-1H-imidazole, or a pharmaceutically acceptable acid addition salt thereof.
Claim 15
Dependent Claim
13 words
The compound which is 1-[2,2-bis(4-cyanobenzylthio)ethyl]-1H-imidazole, or a pharmaceutically acceptable acid addition salt thereof.
Claim 16
Dependent Claim
13 words
The compound which is 1-[2,2-bis(4-cyanobenzylthio)ethyl]-1H-imidazole, or a pharmaceutically acceptable acid addition salt thereof.
Claim 17
Dependent Claim
13 words
The compound which is 1-[2,2-bis(4-aminobenzylthio)ethyl]-1H-imidazole, or a pharmaceutically acceptable acid addition salt thereof.
Claim 18
Dependent Claim
13 words
The compound which is 1-[2,2-bis(4-aminobenzylthio)ethyl]-1H-imidazole, or a pharmaceutically acceptable acid addition salt thereof.
References Cited (Backward Citations)
US3531494A
Cited
US3717655A
Cited
US3793453A
Cited
US3796704A
Cited
US3936470A
Cited
US4062966A
Cited
US4055652A
Cited
US4036970A
Cited
US4036973A
Cited
US4107314A
Cited
EP0001654A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1987-07-03 | 1988-01-02 | 1988-07-03 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1991-07-03 | 1992-01-02 | 1992-07-03 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1995-07-03 | 1996-01-02 | 1996-07-03 | $7700.00 | Window Closed / Lapsed |